Search This Blog

Thursday, April 11, 2019

Teva announces U.S. launch of generic version of AndroGel 1.62% CIII in US

Testosterone Gel 1.62% CIII has annual sales of more than $911M in the U.S., according to IQVIA data as of February.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)